These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7724003)

  • 1. Idiopathic membranous nephropathy in two siblings.
    Maccario M; Segagni S; Efficace E; Piazza V; Poggio F; Villa G; Picardi L; Bovio G; Galli F; Nai M
    Nephrol Dial Transplant; 1995; 10(1):108-10. PubMed ID: 7724003
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of immunosuppressive treatment in patients with membranous nephropathy and renal insufficiency.
    Wetzels JF; Reichert LJ
    Kidney Int Suppl; 1997 Oct; 61():S63-6. PubMed ID: 9328969
    [No Abstract]   [Full Text] [Related]  

  • 3. Idiopathic membranous nephropathy (IMN) in two HLA-identical brothers with different outcome of the disease.
    Grcevska L; Polenakovic M
    Clin Nephrol; 1999 Sep; 52(3):194-6. PubMed ID: 10499319
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
    du Buf-Vereijken PW; Wetzels JF
    Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pulmonary Sarcoidosis associated to crescentic glomerulonephritis: a case report].
    Ferrer Evangelista D; Hernández-Jaras J; Calvo Gordo C; García Pérez H
    An Med Interna; 2002 Dec; 19(12):632-4. PubMed ID: 12593032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prednisolone and chlorambucil therapy for idiopathic membranous nephropathy with progressive renal failure.
    Warwick GL; Geddes CG; Boulton-Jones JM
    Q J Med; 1994 Apr; 87(4):223-9. PubMed ID: 8208913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two brothers with idiopathic membranous nephropathy and familial sensorineural deafness.
    Meroni M; Volpi A; Usberti M; Battini G; Tarelli LT; Giordano F; Sessa A
    Am J Kidney Dis; 1990 Mar; 15(3):269-72. PubMed ID: 2305767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: a nationwide survey in the Netherlands.
    Hofstra JM; Wetzels JF
    Nephrol Dial Transplant; 2008 Nov; 23(11):3534-8. PubMed ID: 18559961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive therapy with cyclophosphamide and prednisolone in severe idiopathic membranous nephropathy.
    Kibriya MG; Tishkov I; Nikolov D
    Nephrol Dial Transplant; 1994; 9(2):138-43. PubMed ID: 8190328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ; Wetzels JF
    Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early prediction of treatment outcome in idiopathic membranous nephropathy.
    O'Callaghan CA; Cameron JS; Sacks SH
    QJM; 1995 Dec; 88(12):889-94. PubMed ID: 8593548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A; Hill GS; Montseny JJ; Meyrier A
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment-related changes in urinary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency.
    du Buf-Vereijken PW; Wetzels JF
    Nephrol Dial Transplant; 2006 Feb; 21(2):389-96. PubMed ID: 16234291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapsing membranous nephropathy with a good response to steroid therapy.
    Tsukada Y; Yano S; Tanaka T; Kitahara T; Takagi C; Kuroiwa T; Shigehara T; Hiromura K; Ueki K; Kanai H; Maezawa A; Naruse T
    Nephron; 1997; 76(2):218-21. PubMed ID: 9200415
    [No Abstract]   [Full Text] [Related]  

  • 15. Idiopathic membranous nephropathy in identical twins.
    Guella A; Akhtar M; Ronco P
    Am J Kidney Dis; 1997 Jan; 29(1):115-8. PubMed ID: 9002539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial membranous nephropathy.
    Scolari F; Amoroso A; Savoldi S; Borelli I; Valzorio B; Costantino E; Bracchi M; Usberti M; Prati E; Maiorca R
    J Nephrol; 1998; 11(1):35-9. PubMed ID: 9561483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
    du Buf-Vereijken PW; Branten AJ; Wetzels JF;
    Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of idiopathic membranous nephropathy: a dilemma or a conundrum?
    Glassock RJ
    Am J Kidney Dis; 2004 Sep; 44(3):562-6. PubMed ID: 15332231
    [No Abstract]   [Full Text] [Related]  

  • 19. Recurrence of idiopathic membranous nephropathy in HLA-identical allograft.
    Agarwal SK; Dash SC; Mehta SN; Bhuyan UN
    Nephron; 1992; 60(3):366. PubMed ID: 1565192
    [No Abstract]   [Full Text] [Related]  

  • 20. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
    Hofstra JM; Deegens JK; Willems HL; Wetzels JF
    Nephrol Dial Transplant; 2008 Aug; 23(8):2546-51. PubMed ID: 18308774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.